Abstract PO3-19-11: CINDERELLA Clinical Trial (NCT05196269): using artificial intelligence-driven healthcare to enhance breast cancer locoregional treatment …
Background. Breast cancer treatment has improved overall survival rates, with different
locoregional approaches offering patients similar locoregional control but variable aesthetic …
locoregional approaches offering patients similar locoregional control but variable aesthetic …
108TiP CINDERELLA clinical trial: Using artificial intelligence-driven healthcare to enhance breast cancer locoregional treatment decisions
Background Breast cancer management often requires a delicate balance between effective
treatments and preserving patient's quality of life. Standardised methods to inform patients …
treatments and preserving patient's quality of life. Standardised methods to inform patients …
CINDERELLA Trial: validation of an artificial-intelligence cloud-based platform to improve the shared decision-making process and outcomes in breast cancer patients …
Background: Breast cancer therapy has made significant progress in improving overall
survival rates, with different surgical approaches offering patients similar locoregional …
survival rates, with different surgical approaches offering patients similar locoregional …
[HTML][HTML] Evaluating the ability of an artificial-intelligence cloud-based platform designed to provide information prior to locoregional therapy for breast cancer in …
Background Breast cancer therapy improved significantly, allowing for different surgical
approaches for the same disease stage, therefore offering patients different aesthetic …
approaches for the same disease stage, therefore offering patients different aesthetic …
The CINDERELLA APProach: Future Concepts for Patient Empowerment in Breast Cancer Treatment with Artificial Intelligence-Driven Healthcare Platform
T Schinköthe, EA Bonci, KP Orit, H Cruz… - European Journal of …, 2024 - ejcancer.com
Background: The CINDERELLA trial (NCT05196269) is designed to determine the efficacy
of the CINDERELLA APProach, an innovative cloud-based healthcare platform, in …
of the CINDERELLA APProach, an innovative cloud-based healthcare platform, in …
Artificial intelligence for prediction of treatment outcomes in breast cancer: Systematic review of design, reporting standards, and bias
Background Artificial intelligence (AI) has the potential to personalize treatment strategies for
patients with cancer. However, current methodological weaknesses could limit clinical …
patients with cancer. However, current methodological weaknesses could limit clinical …
[HTML][HTML] Evolution, current challenges, and future possibilities in the objective assessment of aesthetic outcome of breast cancer locoregional treatment
JS Cardoso, W Silva, MJ Cardoso - The Breast, 2020 - Elsevier
Abstract The Breast Cancer overall survival rate has raised impressively in the last 20 years
mainly due to improved screening and effectiveness of treatments. This increase in survival …
mainly due to improved screening and effectiveness of treatments. This increase in survival …
Abstract OT-39-01: Artificial intelligence supporting cancer patients across Europe-the ASCAPE project for breast cancer patients
A Valachis, S Autexier, I Grau, L Itu, D Jakotevic… - Cancer Research, 2021 - AACR
Background Many breast cancer patients experience adverse effects of cancer or treatment,
which can considerably decrease quality of life (QoL). The current strategy of supporting …
which can considerably decrease quality of life (QoL). The current strategy of supporting …
The role of artificial intelligence in optimising patient recruitment for breast cancer clinical trials
LI Lim, S Puthur, S Mahmoud, L Cooper… - European Journal of …, 2024 - ejso.com
Methods: We retrospectively reviewed breast cancer patients discussed at four
multidisciplinary team meetings in November 2022 at North Manchester General Hospital …
multidisciplinary team meetings in November 2022 at North Manchester General Hospital …
Abstract OT2-06-01: Solti-1903 HOPE: Real-world clinical practice study to assess the impact of using genomic data on the next treatment decision making-choice in …
A Casas, E Ciruelos, M Oliveira, C Saura, M Bellet… - Cancer Research, 2022 - AACR
BACKGROUND: Metastatic breast cancer (mBC) remains an incurable disease and is the
cause of nearly all deaths related to BC. Next-generation sequencing technologies are …
cause of nearly all deaths related to BC. Next-generation sequencing technologies are …